Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting - Seite 2

Documentation

The Invitation to the AGM 2023 with all proposed agenda items is available on the company’s website under this [Link]. The minutes of the AGM will be posted on the AGM page within one week [Link].

 

 

Important dates

24 August 2023 Half-year 2023 results 

 

 

Contact

Doris Rudischhauser

Head of Investor Relations and Corporate Communications

[phone]

[e-mail]

 

 

About Evolva

Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva’s employees, half of which are women, are dedicated to make the best products that can contribute to wellness, health and sustainability. Find out more at evolva.com and connect with us on LinkedIn.

For Evolva multimedia content, please visit: evolva.com/multimedia-library.

 

Disclaimer
This announcement is not an offer of securities into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered, pledged, sold, delivered or otherwise transferred, directly or indirectly, in the United States, except pursuant to an exemption from, or transaction not subject to, the registration requirements of the Securities Act. No public offering of securities is being made in the United States. Further, the securities referred to herein have not been and will not be registered under the applicable securities laws of Canada, Australia or Japan or under the applicable securities laws of any other jurisdiction where to do so might constitute a violation of such laws.